ESOWYN-D
ESOWYN-D, a product of NCB Pharma Private Limited and manufactured by Windlas Biotech, is a powerful combination therapy designed to provide comprehensive relief from acid reflux, GERD, and gastric motility disorders.
Composition:
- Esomeprazole (40 mg, Enteric Coated): A proton pump inhibitor (PPI) that effectively reduces stomach acid production, preventing heartburn and ulcers.
- Domperidone (30 mg): A prokinetic agent that improves stomach emptying and relieves bloating, nausea, and regurgitation.
Key Benefits:
- Fast and long-lasting relief from acidity and GERD
- Prevents acid reflux, heartburn, and indigestion
- Enhances gastric motility and reduces bloating
- Prevents nausea and vomiting caused by delayed stomach emptying
- Protects the oesophagus from acid-related damage
Indications:
- Gastroesophageal Reflux Disease (GERD) with Delayed Gastric Emptying
- Severe Acid Reflux & Heartburn
- Chronic Dyspepsia & Indigestion
- Nausea, Vomiting, and Bloating Associated with Acid Disorders
Recommended Usage: As prescribed by a healthcare professional.
Choose ESOWYN-D from NCB Pharma Private Limited for dual-action relief from acid reflux and gastric discomfort, backed by Windlas Biotech’s trusted manufacturing expertise.
